SMTL ID : 1z6e.1

Factor XA in complex with the inhibitor 1-(3'-amino-1,2-benzisoxazol-5'-yl)-n-(4-(2'-((dimethylamino)methyl)-1h-imidazol-1-yl)-2-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide (razaxaban; DPC906; BMS-561389)

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.80 Å
Oligo State
hetero-oligomer
Ligands
1 x IK8: 1-(3-AMINO-1,2-BENZISOXAZOL-5-YL)-N-(4-{2-[(DIMETHYLAMINO)METHYL]-1H-IMIDAZOL-1-YL}-2-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Quan, M.L. et al., Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4-[(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitor. J.Med.Chem. (2005)
Release Date
2006-03-28
Peptides
Coagulation factor X: A
Coagulation factor X: B
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
L

Coagulation factor X

Coagulation factor X

Related Entries With Identical Sequence

1fjs.1 | 1v3x.1 | 2bmg.1 | 2fzz.1 | 2g00.1 | 2p16.1 | 2p3t.1 | 2p3u.1 | 2p93.1 | 2p94.1 | 2p95.1 | 2phb.1 | 2pr3.1 | 2q1j.1 | 2ra0.1 | 2w26.1 | 2w3i.1 | 2w3k.1 | 3cen.1 | 3cs7.1 | 3ffg.1 | 3kqb.1 | 3kqc.1 | 3kqd.1 | 3kqe.1 | 3liw.1 | 3m36.1 | 3m37.1 | 5k0h.1